In recent years, the adoption of a multidisciplinary approachto the care of patients with cancer has changed the landscapeof oncologic practice. Using this model, surgeons, oncologists,radiologists, pathologists, and others work closely to determinethe optimal approach to management.
The key roles of oncologic imaging in this model are to provideaccurate pretreatment staging of the tumor, to monitor the responseto therapy, and to provide surveillance after curative treatment;thus, the radiologist has an important role in planning routinecancer care. In the light of major advances in cancer treatments,however, there is now a compelling need . . . [Full Text of this Article]
Source Information
From the Academic Department of Radiology, Royal Marsden Hospital, Sutton, United Kingdom.
This article has been cited by other articles:
Schuetze, S. M., Baker, L. H., Benjamin, R. S., Canetta, R.
(2008). Selection of Response Criteria for Clinical Trials of Sarcoma Treatment. The Oncologist
13: 32-40
[Abstract][Full Text]
Choi, S. H., Moon, W. K., Hong, J. H., Son, K. R., Cho, N., Kwon, B. J., Lee, J. J., Chung, J.-K., Min, H. S., Park, S. H.
(2006). Lymph Node Metastasis: Ultrasmall Superparamagnetic Iron Oxide-enhanced MR Imaging versus PET/CT in a Rabbit Model. Radiology
242: 137-143
[Abstract][Full Text]
Fokas, A.S, Iserles, A, Marinakis, V
(2006). Reconstruction algorithm for single photon emission computed tomography and its numerical implementation. J R Soc Interface
3: 45-54
[Abstract][Full Text]
